** Shares of INOVIQ IIQ.AX rise 14.8% to A$0.445, their highest levels since June 10
** The pharmaceutical co says its new cancer treatment kills 88% of breast and lung cancer cells in lab tests
** Around 436,144 shares change hands, vs the 30-day average of 300,505 shares
** Earlier in the day, stock hit its biggest intraday gain since early June
** Stock down 16.5% this year, including the day's move
(Reporting by Shivangi Lahiri in Bengaluru)
((shivangi.lahiri@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.